Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Gunnebo Industrier Holding AB (publ) Interim financial report January – March 2019

Q1 2019Order intake amounted to SEK 257,9 (258,6) million, a decrease of 0,3%.Revenue amounted to SEK 263,5 (247,0) million, an increase of 6,7%.Operating profit before depreciation (EBITDA) was SEK 39,4 (35,6) million.Operating profit (EBIT) was SEK 28,0 (28,5) million.CEO’s comments on Q1Components, Chain & ShacklesThe order intake slowed down in the period mainly due to timing of large stock orders from customers.The order intake decreased by 7,7% to MSEK 201,0 (217,8).Blocks & SheavesStrong order intake from many customers, also from a recovering mobile crane market.

Scandion Oncology A/S announces new date for publication of interim report January – March 2019

Scandion Oncology A/S would like to make use of the full window for releasing the Q1 2019-report. The company therefore releases the Q1 2019-report on May 27, 2019. The previously reported reporting date was May 23, 2019.For further information regarding Scandion Oncology A/S, please contact: Nils Brünner, CEO Phone: +45 26 14 47 08 E-mail: nb@scandiononcology.com  www.scandiononcology.com Scandion Oncology A/S is a biotechnology company founded in 2017 for the purpose of addressing and tackling one of the greatest challenges in modern oncology – the effective treatment of

Isofol’s drug candidate arfolitixorin receives clinical patent approval in the United States

GOTHENBURG, Sweden, May 21, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced approval of a clinical patent for arfolitixorin in the United States. The patent expires in 2038 and is the first in a series of clinical patent applications to reach grant.  It relates to a method of increasing blood concentration of deoxyuridine, a blood biomarker for inhibition of tumor growth in human cancer treatment.Specifically, the now granted patent US 10,292,984 is directed towards a dose regime for the combination of arfolitixorin and 5-fluorouracil injections to

Minutes from Ordinary General Meeting for 2019

The Ordinary General Meeting for 2019 in Nordic Mining ASA was held Tuesday 21 May 2019. All items for consideration were approved.Minutes from the General Meeting in Norwegian and translated into English is attached.For further information, please contact CFO Birte Norheim, telephone +47-95293321.Oslo, 21 May 2019Nordic Mining ASANordic Mining ASA (www.nordicmining.com) Nordic Mining ASA (“Nordic Mining” or the “Company”) is a resource company with focus on high-end industrial minerals and metals. The Company’s project portfolio is of high international standard and holds

Smart Eye announces intention to carry out a directed share issue of up to 15 per cent of the outstanding shares

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE US, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEELAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE CONTRAVENING TO ANY APPLICABLE RULES. ADDITIONAL RESTRICTIONS ARE APPLICABLE, PLEASE SEE “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE.Directed share issue Smart Eye AB (publ) (“Smart Eye” or the “Company”) today announces, based on the authorisation given by the Company’s Annual General Meeting that was

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 21.05.2019

United Bankers Corporation NOTIFICATION 21.05.2019 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 21.05.2019 Date 21.05.2019Exchange transaction BuyShare class UNIAVAmount 413Average price/share 7.8000 EURHighest price/share 7.8000 EURLowest price/share 7.8000 EURTotal price 3,221.40 EUR The shares held by United Bankers Corporation on 21.05.2019: UNIAV 20,507 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ) Antti Salakka  Mikko

Camanio Care performs set-off issue, has possibility to take loan up to 3 million SEK

The Camanio Care board of directors has decided to perform a set-off issue of 15.3 million SEK. The issue is directed at lenders who have accepted to set off loans for the corresponding amount in the issue. Through the issue the balance sheet is strengthened, making it easier to get in new investors and lenders, and at the same time releasing the company from the burden of the interests on those loans. Camanio Care also enters an agreement which gives the company the possibility to loan an additional 3 million SEK. Through these measures, the company has cash to fund the operations until the

Report from Balco Group’s Annual General Meeting 2019

The shareholders of Balco Group AB ("Balco" or "the Company") gathered on Tuesday 21 May 2019 in Växjö, Sweden, for the Annual General Meeting.The Annual General Meeting approved the Company’s and the group’s profit and loss statements and granted the members of the Board of Directors and the CEO discharge from liability for the financial year 2018. The Annual General Meeting resolved to allocate the Company’s profits in accordance with the proposal made by the Board of Directors, meaning dividend of SEK 2 per share. The record date for the dividend was set for 23 May 2019. The Annual

PostNord has issued bonds for SEK 600 million

On Tuesday, May 21, 2019 PostNord AB launched a bond issue for SEK 600 million, of which SEK 250 million is with fixed rate and a five-year maturity and SEK 350 million with floating rate and a five-year maturity. The proceeds from the bond issue will be used among other things to refinance loans falling due. PostNord will list the bonds on Nasdaq OMX Stockholm. Handelsbanken, Nordea and Danske Bank acted as Joint Lead Managers for the transaction. For further information, please contact:PostNord Media Relations, tel +46(0)10-436 10 10, email press@postnord.com Contact person:

Read original

#19-912 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#19-911 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

MIPS acquires patent rights and the brand FLUID

MIPS, the world leader in brain protection systems within helmet-based safety, has today entered into an acquisition agreement for assets that further enhances MIPS’ product offering and safety solutions. The acquisition comprises the brand FLUID and related patent rights associated with a technology that addresses both linear and rotational motions to improve helmet protection. The acquired technology has been developed through a collaboration between Oblique Technology L.P. and the University of Ottawa in Canada, which are also the sellers in the transaction. The technology has so far been

BULLETIN FROM THE ANNUAL GENERAL MEETING IN ONCOPEPTIDES AB (PUBL)

Stockholm, Sweden – 21 May 2019 – Oncopeptides AB (publ)’s (ONCO) Annual General Meeting 2019 was held today, at Tändstickspalatset in Stockholm. At the Annual General Meeting, the following principal resolutions were passed.·  The presented annual report was adopted and the members of the Board of Directors and the CEO were discharged from liability in respect of the financial year 2018. ·  It was resolved to carry forward the result for the year in accordance with the Board of Directors’ proposal. ·  The proposed remunerations to the Board of Directors, its committees and the

AYIMA GROUP AB (PUBL) – AYIMA ANNOUNCES FINAL OUTCOME OF THE RIGHTS ISSUE

The final outcome of Ayima Group AB (publ) (“Ayima” or “the Company”) rights issue of Units totaling approximately SEK 13.6 million, where the subscription period expired on May 15, 2019 shows that 195,161 units was subscribed with support of preferential rights. In addition, 532,105 units were subscribed without support of preferential rights. In total, 727,266 Units, corresponding to 75% of the total rights issue, were subscribed. This means that underwriting guarantees of SEK 1.36 million is required, corresponding to 10% of the total rights issue. Through the rights issue, Ayima will

Cities: Skylines - Campus Expansion Now Available

University is Back in Session, Along with New Jams, a Free Update and MoreSTOCKHOLM - May 21, 2019 - Paradox Interactive and Colossal Order today released the Campus expansion for Cities: Skylines, with new university area types, reputation building, Academic Works, new varsity sports arenas, unique faculties, new policies, achievements and new maps. Available now for $12.99 / £10.29 / €12.99 MSRP, Campus is making school cool again in-game. Check out the trailer: https://www.youtube.com/watch?v=eq5kk4b32rg "Campus expands the way players can interact with the education system in

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Hoover, AL

Free youth baseball clinic to feature seven MLB AlumniColorado Springs, Colo. – Local youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series on Friday, May 24th, 2019. In conjunction with the Southeastern Conference  and ESPN-SEC Network , the free clinic features former Major League Baseball players who will teach baseball skills, drills and life lessons, concluding with an autograph session and baseball

For Immediate Release Significant news for Ileostomy patients from OstomyCure AS

Today the first patient was enrolled in the TIES03 study of the OstomyCure Transcuteous Implant Evacuation System (TIES®). A 64-year-old female from the UK had the TIES port successfully implanted in a procedure that took less than an hour with no complications. “We see the TIES® Solution as a potential step change for ileostomy patients, providing them with a better quality of life” said Prof. David Jayne, who performed the procedure at St. James in Leeds. He continued, “We are delighted to be participating in the TIES® C03 study, as part of the NIHR MedTech in Surgical Technologies, to

iopsys software solutions in strategic software deal in Japan

iopsys software solutions AB announces that its iopsysWrt software has been selected and is successfully implemented in iTUS next-generation G.fast Gateway products.   ITUS, the Japanese part of N-iTUS, is a well-known Korean supplier of access equipment and CPE’s. ITUS selected iopsysWrt for its Vnet series of G.fast residential gateway targeting the fast growing Japanese market. iopsysWrt is an enterprise software for CPE and gateway products. It provides a full enterprise solution with security enhancements and feature rich services such as local and remote management,

Fortum participates at Uniper’s Annual General Meeting for the first time

FORTUM CORPORATION PRESS RELEASE 21 MAY 2019 Uniper SE is hosting its Annual General Meeting in Düsseldorf, Germany, on 22 May 2019. With its 49.99% holding, Fortum is Uniper’s largest shareholder and will now be represented at the AGM for the first time since closing of the Public Tender Offer (PTO) on Uniper in June 2018. In addition to a listed company’s regular agenda items, Uniper’s other major shareholders, Cornwall GmbH & Co. KG (Elliott) and KVIP International V L.P. (Knight Vinke), had put forward motions on the agenda on a DPLTA (domination agreement) and spin-off of Uniper’

Report from the Annual General Meeting of Promore Pharma AB held on 21 May 2019

STOCKHOLM, 21 May, 2019 – Promore Pharma AB held its AGM on Tuesday, 21 May 2019. The main resolutions passed at the meeting were as follows.More detailed information about the contents of the resolutions may be obtained from the complete notice of the AGM and the complete proposals. The notice and complete proposals are available on the Company’s website, www.promorepharma.com. Adoption of balance sheets and profit and loss accounts It was resolved at the meeting to adopt the profit and loss account and balance sheet, as well as the consolidated profit and loss account and

Vestas introduces the V138-3.0 MW – the next EnVentus variant, leveraging modular platform architecture to meet market constraints and reduce LCoE

News release from Vestas Wind Systems A/SAarhus, 21 May Following the launch of the EnVentus platform in January, including the V162-5.6 MW and V150-5.6 MW turbines, Vestas today introduced the V138-3.0 MW turbine at AWEA WINDPOWER in Houston, Texas. Based on the scalable EnVentus platform architecture, the V138-3.0 MW’s 138m rotor provides a large rotor-size-to-generator-rating ratio, strengthening Vestas’ portfolio of turbines through superior park level energy production, higher certainty in performance, and reduced levelised cost of energy. The V138-3.0 MW is globally applicable

Handheld announces continued availability of Windows Embedded Handheld (WEH) on the NAUTIZ X8 rugged computer

[Lidköping, Sweden, May 21, 2019.] Handheld Group , a leading manufacturer of rugged mobile computers, today emphasized that it will continue producing and supporting the NAUTIZ X8 ultra-rugged handheld computer that operates on the Windows Embedded Handheld (WEH) operating system. The NAUTIZ X8 rugged handheld is designed for tough environments and runs WEH 6.5. Microsoft’s announcement that it will discontinue support for WEH in January 2020 has implications for companies which have invested in Windows-based handheld computers, and those who have

We Are Not Alone! Stellaris: Console Edition Gets Multiplayer Today

The Free Update Comes to All Human Players on Xbox and PS4STOCKHOLM - May 21, 2019 - Prepare your parties! Paradox Interactive, a publisher and developer of games brimming with sentient life, and Tantalus Media have today launched multiplayer for up to four players in Stellaris: Console Edition. Pursue your galactic ambitions cooperatively or vie against one another to completely crush the hard-won empires of your closest friends and family. Multiplayer is now available for free to all Stellaris: Console Edition players on Xbox and PlayStation. Join the spacefaring community now: https://

There are no items matching the current filter
There are no more items matching the current filter
Back to top